These days you can post updates about your life on Facebook, Twitter, Instagram, and many other social media sites. You can send e-mails for private or targeted messages. You can text someone if it’s urgent (God forbid you actually talk to... Read more »
It was a beautiful, brisk fall day last Tuesday at the deCordova Sculpture Park and Museum in Lincoln, MA. Xconomy took over the entire museum for the day for our second, invitation-only Healthcare Summit. The day featured a series of chats... Read more »
Polaris Partners, a Boston-based venture capital firm with heavy historical ties to MIT’s biotech research labs, has raised $450 million for a seventh fund.
The new fund is slightly larger than the $400 million targeted in initial SEC filings earlier... Read more »
It wasn’t too long ago that Prosensa Holding was kicked to the curb by Wall Street investors. Following a failed Phase 3 trial for its Duchenne Muscular Dystrophy drug and a decision by GlaxoSmithKline to dump a partnership between the two... Read more »
Among the slew of challenges in drug development, there’s this: how can you efficiently get a big molecule, like a protein or nucleic acid, into a cell?
That quandary has bedeviled a number of efforts to make and deliver drugs over... Read more »
The role of the trillions of microbes in the human body is poorly understood—and that’s even more so in plants. A growing number of companies are trying to harness the power of microscopic bugs that live in and around plants to... Read more »
If there was a theme to Bill Aulet’s swing through San Diego last week, it was that entrepreneurship is a skill that can be learned.
But that doesn’t necessarily mean that entrepreneurship can be taught. In fact, if there was a... Read more »
At a gathering held for reporters last night in New York, folks from Verizon Wireless sought to talk up some of the ways the wireless carrier works with third-party technology developers.
Nothing groundbreaking was announced, yet Verizon Wireless of Basking Ridge, NJ, seemed... Read more »
One of the year’s biggest cancer meetings took place this week in Barcelona, and many biotechs from the East Coast were angling for the spotlight. Some wowed investors, others, not so much. We’ve got the ups and downs and the... Read more »
Trying to run an electric car from solar cells on the car’s roof makes no sense—or so I thought. Earlier this week, I met with Daniel Theobald, the CTO of healthcare company Vecna, who has been driving a solar-powered Volkswagen bus... Read more »